tiprankstipranks
Trending News
More News >
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Income Statement

Compare
2,525 Followers

Catalyst Pharma Income Statement

Last quarter (Q4 2025), Catalyst Pharma's total revenue was $152.61M, an increase of 7.61% from the same quarter last year. In Q4, Catalyst Pharma's net income was $52.70M. See Catalyst Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 588.99M$ 491.73M$ 398.20M$ 214.20M$ 140.83M
Gross Profit
$ 501.74M$ 422.89M$ 346.24M$ 179.81M$ 118.95M
Operating Expenses
$ 243.96M$ 227.76M$ 259.43M$ 77.97M$ 66.56M
Depreciation and Amortization
$ 37.50M$ 37.77M$ 32.88M$ 1.24M$ 192.00K
EBITDA
$ 321.01M$ 232.90M$ 119.69M$ 103.08M$ 52.58M
Operating Income
$ 257.78M$ 195.12M$ 86.81M$ 101.84M$ 52.38M
Other Income/Expenses
$ 25.74M$ 21.14M$ 7.70M$ 2.88M$ 282.00K
Pretax Income
$ 283.51M$ 216.26M$ 94.51M$ 104.72M$ 52.67M
Net Income
$ 214.33M$ 163.89M$ 71.41M$ 83.08M$ 39.48M
Per Share Metrics
Basic EPS
$ 1.75$ 1.38$ 0.67$ 0.80$ 0.38
Diluted EPS
$ 1.68$ 1.31$ 0.63$ 0.75$ 0.37
Weighted Average Shares Outstanding
122.29M 118.46M 106.28M 103.37M 103.38M
Weighted Average Shares Outstanding (Diluted)
127.26M 124.94M 113.75M 111.38M 107.80M
Currency in USD

Catalyst Pharma Earnings and Revenue History